Terrence W. Norchi
Guest Writer
/ CEO of Arch Therapeutics, Inc.
Terrence W. Norchi, MD is president and CEO of Framingham, MA-based Arch Therapeutics, Inc. Arch’s flagship development stage product candidate, the AC5 Surgical Hemostatic Device™, is being designed to achieve hemostasis in minimally invasive and open surgical procedures.
More From Terrence W. Norchi
C-Suite
5 Ways Varied Job Experience Helps Your Career
Job doesn't match your degree? Fear not. It might actually help you get -- and thrive in -- the job you want.
